ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,352Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 2035

$748K Total Retail Price of All Prescriptions

Rank: 119 out of 2035

256 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

46% of this provider’s 256 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

37% of this provider’s 256 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 6,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
OXYCODONE HCL 632 276 S2 1 62
FUROSEMIDE 508 238 2 7
METOPROLOL TARTRATE 491 280 3 8
HYDROCODONE-ACETAMINOPHEN 453 228 S3 4 2
PROAIR HFA 421 163 5 31
OMEPRAZOLE 391 180 6 5
LISINOPRIL 384 187 7 3
SIMVASTATIN 370 202 8 1
LOSARTAN POTASSIUM 301 210 9 15
FLOVENT HFA 270 100 10 10 238
METFORMIN HCL 264 158 11 9
HYDROCHLOROTHIAZIDE 260 155 12 12
CLOPIDOGREL 254 151 13 30
AMLODIPINE BESYLATE 251 156 14 6
POTASSIUM CHLORIDE 225 85 15 18
ISOSORBIDE MONONITRATE ER 211 154 16 32
LEVOTHYROXINE SODIUM 190 95 17 4
LOVASTATIN 185 144 18 33
PLAVIX 174 106 19 49
MIRTAZAPINE 169 72 20 46
SPIRIVA 167 63 21 44
RANITIDINE HCL 151 90 22 28
ZOLPIDEM TARTRATE 136 49 23 21
CITALOPRAM HBR 132 41 24 20
DIOVAN 129 84 25 76
GABAPENTIN 128 58 26 14
ATORVASTATIN CALCIUM 113 65 27 13
LYRICA 102 32 28 89
VENTOLIN HFA 92 51 29 80
ADVAIR DISKUS 90 45 30 38
METHYLPREDNISOLONE 89 36 31 125
PANTOPRAZOLE SODIUM 85 49 32 42
CLOBETASOL PROPIONATE 85 38 32 288
OXYBUTYNIN CHLORIDE 84 43 34 102
TORSEMIDE 83 41 35 157
LIDODERM 83 37 35 72
HYDRALAZINE HCL 77 39 37 45
PEN NEEDLE 77 19 37 100
AMMONIUM LACTATE 75 28 39 155
NOVOLOG FLEXPEN 73 13 40 133
CLONIDINE HCL 72 26 41 61
WARFARIN SODIUM 72 39 41 11
NITROSTAT 69 54 43 167
FINASTERIDE 66 61 44 105
LANTUS SOLOSTAR 65 0 45 66
OPANA ER 65 29 S2 45 172
CARVEDILOL 64 34 47 22
KETOCONAZOLE 63 39 48 215
METOPROLOL SUCCINATE 61 35 49 16
NEXIUM 58 31 50 51
LANTUS 57 15 51 40
NAPROXEN SODIUM 55 23 52 269
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 14 52 26
ALCOHOL SWABS 52 0 54 182
TAMSULOSIN HCL 52 36 54 25
AMOXICILLIN 51 12 56 116
CHANTIX 50 15 57 480
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.